Results 141 to 150 of about 29,880 (268)

The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

British Journal of Clinical Pharmacology, EarlyView.
Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez, Gülnihal Özcan, Hakan S. Orer   +2 more
wiley   +1 more source

Moral Hazards and Negative Externalities of Lifesaving Programs: How Naloxone Access Laws and Prescription Drug Monitoring Programs Affect HIV Transmission

, 2020
This paper looks at naloxone access laws and prescription drug monitering programs and see how these programs affect HIV transmission and drug overdose deaths. Using an OLS regression I find that NAL reduces HIV and increases overdose deaths. I also find
Horn, Jeremy
core  

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development

Journal of Pain Research, 2016
Jeffrey Fudin,1 Jacqueline Pratt Cleary,2 Michael E Schatman31Western New England University College of Pharmacy, Springfield, MA, 2Stratton VA Medical Center, Albany, NY, 3US Pain Foundation, Bellevue, WA, USAWith the opioid-misuse and -abuse problem on
Fudin J, Pratt Cleary J, Schatman ME
doaj  

State Policies for Prescription Drug Monitoring Programs and Adverse Opioid-related Hospital Events. [PDF]

Med Care, 2020
Wen K, Johnson P, Jeng PJ, Schackman BR, Bao Y.   +4 more
europepmc   +1 more source

Fostering medication review competence of pharmacy students: An assessment by students and their preceptors after advanced‐level practical internship

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study was to introduce a new assessment method for pharmacy students' real‐life competence in reviewing medications after obligatory advanced‐level practical internship in Finland. Methods The new medication review (MR) competence assessment method consisted of (1) a self‐assessment by pharmacy students and (2) a performance ...
Katja Leiman, Aleksi Westerholm, Tero Vahlberg, Noora Lias, Tanja Lindholm, Marja Airaksinen   +5 more
wiley   +1 more source

Today’s nonmedical opioid users are not yesterday’s patients; implications of data indicating stable rates of nonmedical use and pain reliever use disorder

Journal of Pain Research, 2019
Jeffrey A Singer,1–3 Jacob Z Sullum,4,5 Michael E Schatman6,7 1Valley Surgical Clinics, Ltd., Phoenix, AZ, USA; 2Department of Health Policy Studies and Center for the Study of Science, Cato Institute, Washington, DC, USA; 3Goldwater Institute ...
Singer JA, Sullum JZ, Schatman ME
doaj  

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Policing alcohol and illicit drug use among Aboriginal and Torres Strait Islander people in metropolitan environments [PDF]

, 2014
Executive summary: This report presents the results of Australian Institute of Criminology research on issues and challenges of policing alcohol and illicit drug use among Aboriginal and Torres Strait Islander people in metropolitan environments.
David Marks, Jason Payne, Tracy Cussen
core  

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source